Author:
Steiner Israel,Mosberg-Galili Ronit
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference11 articles.
1. Behan PO, Chaudhuri A (2010) The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy. Inflammopharmacology. Sep 24 [Epub ahead of print]
2. Behan PO, Chaudhuri A, Roep BO (2002) The pathogenesis of multiple sclerosis revisited. J R Coll. Physicians Edinb 32:244–265
3. Brown MG, Kirby S, Skedgel C et al (2007) How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Neurology 69:1498–1507
4. Doepp F, Paul F, Valdueza JM et al (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 68:173–183
5. Frohman EM, Stüve O, Havrdova E et al (2005) Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch Neurol 62:1519–1530
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献